Vijay Satyanand Pande - Net Worth and Insider Trading
Vijay Satyanand Pande Net Worth
The estimated net worth of Vijay Satyanand Pande is at least $64 Million dollars as of 2024-11-13. Vijay Satyanand Pande is the Director of Bioage Labs Inc and owns about 3,233,170 shares of Bioage Labs Inc (BIOA) stock worth over $64 Million. Details can be seen in Vijay Satyanand Pande's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vijay Satyanand Pande has not made any transactions after 2024-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vijay Satyanand Pande
Vijay Satyanand Pande Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vijay Satyanand Pande owns 1 companies in total, including Nautilus Biotechnology Inc (NAUT) .
Click here to see the complete history of Vijay Satyanand Pande’s form 4 insider trades.
Insider Ownership Summary of Vijay Satyanand Pande
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NAUT | Nautilus Biotechnology Inc | 2021-06-09 | director |
Vijay Satyanand Pande Latest Holdings Summary
Vijay Satyanand Pande currently owns a total of 1 stock. Vijay Satyanand Pande owns 3,233,170 shares of Bioage Labs Inc (BIOA) as of October 3, 2024, with a value of $64 Million.
Latest Holdings of Vijay Satyanand Pande
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIOA | Bioage Labs Inc | 2024-10-03 | 3,233,170 | 19.92 | 64,404,746 |
Holding Weightings of Vijay Satyanand Pande
Vijay Satyanand Pande Form 4 Trading Tracker
According to the SEC Form 4 filings, Vijay Satyanand Pande has made a total of 2 transactions in Bioage Labs Inc (BIOA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Bioage Labs Inc is the acquisition of 219,195 shares on October 3, 2024, which cost Vijay Satyanand Pande around $4 Million.
Insider Trading History of Vijay Satyanand Pande
- 1
Vijay Satyanand Pande Trading Performance
GuruFocus tracks the stock performance after each of Vijay Satyanand Pande's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vijay Satyanand Pande is %. GuruFocus also compares Vijay Satyanand Pande's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vijay Satyanand Pande within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vijay Satyanand Pande's insider trading performs compared to the benchmark.
Performance of Vijay Satyanand Pande
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.8 |  | | | | |
| Relative Return to S&P 500(%) | 8.94 | | | | | |
Vijay Satyanand Pande Ownership Network
Ownership Network List of Vijay Satyanand Pande
Ownership Network Relation of Vijay Satyanand Pande
Vijay Satyanand Pande Owned Company Details
What does Nautilus Biotechnology Inc do?
Who are the key executives at Nautilus Biotechnology Inc?
Vijay Satyanand Pande is the director of Nautilus Biotechnology Inc. Other key executives at Nautilus Biotechnology Inc include Senior VP & Operations Mary E. Godwin , director & 10 percent owner & CEO & President & and Secretary Sujal M Patel , and Senior VP & Product Development Subramanian Sankar .
Nautilus Biotechnology Inc (NAUT) Insider Trades Summary
Over the past 18 months, Vijay Satyanand Pande made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net sale of 82,031 shares made by Mary E. Godwin , and a net purchase of 50,000 shares made by Sujal M Patel .
In summary, during the past 3 months, insiders sold 82,031 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 0 shares, with a net sale of 82,031 shares. During the past 18 months, 82,031 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 32,031 shares.
Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nautilus Biotechnology Inc Insider Transactions
Vijay Satyanand Pande Mailing Address
Above is the net worth, insider trading, and ownership report for Vijay Satyanand Pande. You might contact Vijay Satyanand Pande via mailing address: 2865 Sand Hill Road, Suite 101, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
